功能性食物的审查 调节炎性肠病 (IBD) 中肠道微生物群和母细胞功能
Arumugam Vignesh1, Thomas Cheeran Amal2, Raya Soltane3
1Department of Botany, NGM College (Autonomous), Tamil Nadu, Pollachi, 642 001, India. arumugamvignesh@ngmc.org.
Probiotics and antimicrobial proteins
|September 27, 2025
概括
功能性食物,如益生菌和益生菌,为炎症性肠病 (IBD) 提供了有前途的辅助疗法. 这些饮食干预可以帮助管理肠道炎症,并通过调节微生物群和免疫反应来改善患者的结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 营养科学 营养科学
背景情况:
- 炎症性肠病 (IBD) 是一种慢性疾病,其特征是肠道炎症,失生症和免疫功能障碍.
- 目前的IBD疗法具有显著的副作用,推动了对更安全的替代品的需求.
- 正在研究功能性食品作为IBD的补充治疗方法.
研究的目的:
- 审查功能性食品作为辅助疗法的潜力,用于管理炎症性肠病 (IBD).
- 探索功能性食品在IBD中发挥抗炎作用的机制.
- 讨论影响IBD功能性食物临床应用和未来研究方向的因素.
主要方法:
- 对功能性食品 (益生菌,益生菌,多,欧米茄-3脂肪酸) 的研究和它们对IBD的影响的文献综述.
- 分析包括肠道微生物组调节,抗炎性质和免疫反应调节在内的机制.
- 讨论临床整合的实际障碍和优化策略.
主要成果:
- 功能性食物调节肠道微生物群,增强抗炎代谢物,并具有抗氧化特性.
- 欧米茄-3脂肪酸抑制促炎性细胞因子,而多稳定巨细胞.
- 这些食物可以恢复微生物平衡,改善肠道屏障功能,调节免疫反应.
结论:
- 功能性食品显示出作为IBD辅助疗法的潜力,减少对常规药物的依赖.
- 优化剂量,生物可用性和解决配方稳定性对于临床成功至关重要.
- 需要进一步的研究,以充分阐明机制,并建立最佳的临床协议功能性食品在IBD管理.
更多相关视频
相关概念视频
Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Functions of the Gut Microbiota
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...


